Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. (Record no. 9574538)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02288 a2200709 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513143533.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199806s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0022-1899 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1086/515331 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Ockenhouse, C F |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19980618 |
245 00 - TITLE STATEMENT | |
Title | Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The Journal of infectious diseases |
Date of publication, distribution, etc. | Jun 1998 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1664-73 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Amino Acid Sequence |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Protozoan |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antigens, Protozoan |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Consumer Product Safety |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genetic Vectors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Malaria Vaccines |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Molecular Sequence Data |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | T-Lymphocytes, Cytotoxic |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vaccines, Attenuated |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vaccines, Synthetic |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vaccinia virus |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Viral Proteins |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Viral Vaccines |
General subdivision | adverse effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sun, P F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lanar, D E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wellde, B T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hall, B T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kester, K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stoute, J A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Magill, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Krzych, U |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Farley, L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wirtz, R A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sadoff, J C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kaslow, D C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kumar, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Church, L W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Crutcher, J M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wizel, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hoffman, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lalvani, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hill, A V |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tine, J A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Guito, K P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | de Taisne, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Anders, R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ballou, W R |
773 0# - HOST ITEM ENTRY | |
Title | The Journal of infectious diseases |
Related parts | vol. 177 |
-- | no. 6 |
-- | p. 1664-73 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1086/515331">https://doi.org/10.1086/515331</a> |
Public note | Available from publisher's website |
No items available.